145 related articles for article (PubMed ID: 10595568)
1. A 1997-1998 national surveillance study: Moraxella catarrhalis and Haemophilus influenzae antimicrobial resistance in 34 US institutions.
Richter SS; Brueggemann AB; Huynh HK; Rhomberg PR; Wingert EM; Flamm R; Doern GV
Int J Antimicrob Agents; 1999 Oct; 13(2):99-107. PubMed ID: 10595568
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic resistance in respiratory tract isolates of Haemophilus influenzae and Moraxella catarrhalis collected from across Canada in 1997-1998.
Zhanel GG; Karlowsky JA; Low DE; Hoban DJ
J Antimicrob Chemother; 2000 May; 45(5):655-62. PubMed ID: 10797089
[TBL] [Abstract][Full Text] [Related]
3. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
Harrison CJ; Woods C; Stout G; Martin B; Selvarangan R
J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
[TBL] [Abstract][Full Text] [Related]
4. Apparent plateau in beta-lactamase production among clinical isolates of Haemophilus influenzae and Moraxella catarrhalis in the United States: results from the LIBRA Surveillance initiative.
Jones ME; Karlowsky JA; Blosser-Middleton R; Critchley IA; Thornsberry C; Sahm DF
Int J Antimicrob Agents; 2002 Feb; 19(2):119-23. PubMed ID: 11850164
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of Canadian isolates of Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae to oral antimicrobial agents.
Blondeau JM; Vaughan D; Laskowski R; Borsos S;
Int J Antimicrob Agents; 2001 Jun; 17(6):457-64. PubMed ID: 11397615
[TBL] [Abstract][Full Text] [Related]
6. The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections.
Hoban D; Felmingham D
J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():49-59. PubMed ID: 12239228
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibilities of clinical isolates of Haemophilus influenzae and Moraxella catarrhalis collected during 1999-2000 from 13 countries.
Turnak MR; Bandak SI; Bouchillon SK; Allen BS; Hoban DJ
Clin Microbiol Infect; 2001 Dec; 7(12):671-7. PubMed ID: 11843908
[TBL] [Abstract][Full Text] [Related]
8. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998.
Thornsberry C; Jones ME; Hickey ML; Mauriz Y; Kahn J; Sahm DF
J Antimicrob Chemother; 1999 Dec; 44(6):749-59. PubMed ID: 10590275
[TBL] [Abstract][Full Text] [Related]
9. Non-susceptibility trends among Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections in the UK and Ireland, 1999-2007.
Morrissey I; Maher K; Williams L; Shackcloth J; Felmingham D; Reynolds R;
J Antimicrob Chemother; 2008 Nov; 62 Suppl 2():ii97-103. PubMed ID: 18819984
[TBL] [Abstract][Full Text] [Related]
10. Development of beta-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978-1993.
Nissinen A; Grönroos P; Huovinen P; Herva E; Katila ML; Klaukka T; Kontiainen S; Liimatainen O; Oinonen S; Mäkelä PH
Clin Infect Dis; 1995 Nov; 21(5):1193-6. PubMed ID: 8589142
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study.
Doern GV; Brueggemann AB; Pierce G; Hogan T; Holley HP; Rauch A
Antimicrob Agents Chemother; 1996 Dec; 40(12):2884-6. PubMed ID: 9124860
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic susceptibilities among recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis from fifteen countries.
Bandak SI; Turnak MR; Allen BS; Bolzon LD; Preston DA; Bouchillon SK; Hoban DJ
Eur J Clin Microbiol Infect Dis; 2001 Jan; 20(1):55-60. PubMed ID: 11245326
[TBL] [Abstract][Full Text] [Related]
13. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998.
Sahm DF; Jones ME; Hickey ML; Diakun DR; Mani SV; Thornsberry C
J Antimicrob Chemother; 2000 Apr; 45(4):457-66. PubMed ID: 10747822
[TBL] [Abstract][Full Text] [Related]
14. Increasing antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Finland.
Manninen R; Huovinen P; Nissinen A
J Antimicrob Chemother; 1997 Sep; 40(3):387-92. PubMed ID: 9338492
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated in the UK from sputa.
Powell M; McVey D; Kassim MH; Chen HY; Williams JD
J Antimicrob Chemother; 1991 Aug; 28(2):249-59. PubMed ID: 1778856
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibilities of 180 clinical isolates of Haemophilus influenzae to ampicillin, amoxycillin/clavulanate, cefaclor, cefuroxime, cefotaxime, clarithromycin, and azithromycin.
Delmée M; Carpentier M; Glupczynski Y; Gordts B; Magerman K; Simon A; Surmont I; Van de Vyvere M; Van Landuyt H; Van Nimmen L; Van Noyen R
Acta Clin Belg; 1996; 51(4):237-43. PubMed ID: 8858889
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002.
Zhanel GG; Palatnick L; Nichol KA; Low DE; Hoban DJ;
Antimicrob Agents Chemother; 2003 Jun; 47(6):1875-81. PubMed ID: 12760861
[TBL] [Abstract][Full Text] [Related]
18. The Italian Epidemiological Survey 1997-1999. Antimicrobial susceptibility data of Haemophilus influenzae, Haemophilus parainfluenzae and Moraxella catarrhalis in Italy.
Nicoletti G; Blandino G; Caccamo F; Friscia O; Schito AM; Speciale A;
Int J Antimicrob Agents; 2002 Oct; 20(4):263-9. PubMed ID: 12385682
[TBL] [Abstract][Full Text] [Related]
19. Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis. Canadian Antimicrobial Study Group.
Blondeau JM; Suter M; Borsos S
J Antimicrob Chemother; 1999 Mar; 43 Suppl A():25-30. PubMed ID: 10225568
[TBL] [Abstract][Full Text] [Related]
20. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group.
Thornsberry C; Ogilvie P; Kahn J; Mauriz Y
Diagn Microbiol Infect Dis; 1997 Dec; 29(4):249-57. PubMed ID: 9458982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
